Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Home Newsfeeds Syros Pharmaceuticals Says Regained Compliance With NASDAQ Minimum Bid Requirement

Syros Pharmaceuticals Says Regained Compliance With NASDAQ Minimum Bid Requirement

-SEC Filing

October 6, 2022

1 minute read

-SEC Filing

Apple Plans to Start Manufacturing iPhone 14 in India After Initial Release Out of China

August 23, 5:08 AM

-Bloomberg https://www.bloomberg.com/news/articles/2022-08-23/apple-s-new-iphone-14-to-show-india-closing-tech-gap-with-china-l75ofck3

February 6, 7:45 AM

Citigroup analyst Christopher Danely maintains Qualcomm (NASDAQ:QCOM) with a Neutral and raises the price target from $105 to $132.

November 10, 3:43 PM

Mizuho analyst Dan Dolev reiterated the Underperform rating on Coinbase Global, Inc. (NASDAQ: COIN),

August 10, 9:21 AM

Morgan Stanley analyst Keith Weiss maintains Akamai Technologies (NASDAQ:AKAM) with a Equal-Weight and lowers the price target from $110 to $102.